Literature DB >> 9356550

Bacterial fermentation of fructooligosaccharides and resistant starch in patients with an ileal pouch-anal anastomosis.

M S Alles1, M B Katan, J M Salemans, K M Van Laere, M J Gerichhausen, M J Rozendaal, F M Nagengast.   

Abstract

Patients with large bowel disease may undergo ileal pouch-anal anastomosis, in which the colon is removed and part of the distal ileum is used to construct a pelvic reservoir. Competence of the ileal pouch to ferment carbohydrates is associated with the absence of pouchitis. However, the extent to which bacterial fermentation takes place and whether it is affected by diet are unclear. We investigated fermentation of two nondigestible carbohydrates, fructooligosaccharides and resistant starch, in 15 healthy patients with an ileal pouch by using a placebo-controlled crossover design (with glucose as the placebo). Apparent fermentability of fructooligosaccharides was 83%; that of resistant starch was 46%. Resistant starch increased fecal excretion of butyrate by 69% whereas fructooligosaccharides reduced excretion of amino acid-derived isobutyrate by 94% and of isovalerate by 77%. Fructooligosaccharides also significantly increased fecal weight (651 compared with 541 g/d) and breath-hydrogen excretion (286 compared with 85 ppm x h). Bacterial fermentation of nondigestible carbohydrates in pouches takes place to an appreciable extent and in a substrate-specific manner. The relation between such fermentation and inflammation of the pouch (pouchitis) deserves study.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9356550     DOI: 10.1093/ajcn/66.5.1286

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  7 in total

1.  Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome.

Authors:  Bruno P Chumpitazi; Emily B Hollister; Numan Oezguen; Cynthia M Tsai; Ann R McMeans; Ruth A Luna; Tor C Savidge; James Versalovic; Robert J Shulman
Journal:  Gut Microbes       Date:  2014-01-27

2.  Effects of intervention with sulindac and inulin/VSL#3 on mucosal and luminal factors in the pouch of patients with familial adenomatous polyposis.

Authors:  Pieter Friederich; Jelle Verschuur; Bjorn W H van Heumen; Hennie M J Roelofs; Marloes Berkhout; Iris D Nagtegaal; Martijn G H van Oijen; Johannes H J M van Krieken; Wilbert H M Peters; Fokko M Nagengast
Journal:  Int J Colorectal Dis       Date:  2011-01-18       Impact factor: 2.571

Review 3.  Towards microbial fermentation metabolites as markers for health benefits of prebiotics.

Authors:  Kristin A Verbeke; Alan R Boobis; Alessandro Chiodini; Christine A Edwards; Anne Franck; Michiel Kleerebezem; Arjen Nauta; Jeroen Raes; Eric A F van Tol; Kieran M Tuohy
Journal:  Nutr Res Rev       Date:  2015-06       Impact factor: 7.800

Review 4.  Biomarkers for nutrient intake with focus on alternative sampling techniques.

Authors:  T Holen; F Norheim; T E Gundersen; P Mitry; J Linseisen; P O Iversen; C A Drevon
Journal:  Genes Nutr       Date:  2016-04-16       Impact factor: 5.523

Review 5.  Potential Benefits of Dietary Fibre Intervention in Inflammatory Bowel Disease.

Authors:  Celestine Wong; Philip J Harris; Lynnette R Ferguson
Journal:  Int J Mol Sci       Date:  2016-06-14       Impact factor: 5.923

Review 6.  A Personalized Approach to Managing Patients With an Ileal Pouch-Anal Anastomosis.

Authors:  Zaid S Ardalan; Miles P Sparrow
Journal:  Front Med (Lausanne)       Date:  2020-01-29

7.  Effects of prebiotic consumption on serum intestinal fatty acid-binding protein levels in patients with diabetes: A case-control study.

Authors:  Yi-Cheng Hou; Chien-Wen Lai; Ching-Feng Cheng; Yi-Ying Lin; Tsung-Han Hsieh; Jing Hui Wu; I-Shiang Tzeng; Chan-Yen Kuo
Journal:  J Clin Lab Anal       Date:  2020-07-22       Impact factor: 2.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.